220 related articles for article (PubMed ID: 16356222)
1. Anti-L-selectin antibody therapy does not worsen the postseptic course in a baboon model.
Redl HR; Martin U; Khadem A; Pelinka LE; van Griensven M
Crit Care; 2005; 9(6):R735-44. PubMed ID: 16356222
[TBL] [Abstract][Full Text] [Related]
2. Antibody to E- and L-selectin does not prevent lung injury or mortality in septic baboons.
Carraway MS; Welty-Wolf KE; Kantrow SP; Huang YC; Simonson SG; Que LG; Kishimoto TK; Piantadosi CA
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):938-49. PubMed ID: 9517615
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokines increase in sepsis after anti-adhesion molecule therapy.
Welty-Wolf KE; Carraway MS; Ghio A; Kantrow SP; Huang YC; Piantadosi CA
Shock; 2000 May; 13(5):404-9. PubMed ID: 10807017
[TBL] [Abstract][Full Text] [Related]
4. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).
Hinshaw LB; Tekamp-Olson P; Chang AC; Lee PA; Taylor FB; Murray CK; Peer GT; Emerson TE; Passey RB; Kuo GC
Circ Shock; 1990 Mar; 30(3):279-92. PubMed ID: 2178801
[TBL] [Abstract][Full Text] [Related]
5. Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-alpha.
Jansen PM; de Jong IW; Hart M; Kim KJ; Aarden LA; Hinshaw LB; Taylor FB; Hack CE
J Immunol; 1996 Jun; 156(11):4401-7. PubMed ID: 8666813
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody to tumor necrosis factor--alpha prevents lethal endotoxin sepsis in adult rhesus monkeys.
Fiedler VB; Loof I; Sander E; Voehringer V; Galanos C; Fournel MA
J Lab Clin Med; 1992 Oct; 120(4):574-88. PubMed ID: 1402333
[TBL] [Abstract][Full Text] [Related]
7. Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody.
Hinshaw LB; Emerson TE; Taylor FB; Chang AC; Duerr M; Peer GT; Flournoy DJ; White GL; Kosanke SD; Murray CK
J Trauma; 1992 Oct; 33(4):568-73. PubMed ID: 1433404
[TBL] [Abstract][Full Text] [Related]
8. Anti-L-selectin antibody treatment of hemorrhagic-traumatic shock in baboons.
Schlag G; Redl HR; Till GO; Davies J; Martin U; Dumont L
Crit Care Med; 1999 Sep; 27(9):1900-7. PubMed ID: 10507616
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model.
Emerson TE; Lindsey DC; Jesmok GJ; Duerr ML; Fournel MA
Circ Shock; 1992 Oct; 38(2):75-84. PubMed ID: 1423924
[TBL] [Abstract][Full Text] [Related]
10. Repeated administration of a F(ab')2 fragment of an anti-tumor necrosis factor alpha monoclonal antibody in patients with severe sepsis: effects on the cardiovascular system and cytokine levels.
Boekstegers P; Weidenhöfer S; Zell R; Pilz G; Holler E; Ertel W; Kapsner T; Redl H; Schlag G; Kaul M
Shock; 1994 Apr; 1(4):237-45. PubMed ID: 7735957
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
Creasey AA; Chang AC; Feigen L; Wün TC; Taylor FB; Hinshaw LB
J Clin Invest; 1993 Jun; 91(6):2850-60. PubMed ID: 8514893
[TBL] [Abstract][Full Text] [Related]
12. Hyperdynamic sepsis in baboons: I. Aspects of hemodynamics.
Schlag G; Redl H; Hallström S; Radmore K; Davies J
Circ Shock; 1991 Jul; 34(3):311-8. PubMed ID: 1884434
[TBL] [Abstract][Full Text] [Related]
13. Hyperdynamic sepsis in baboons: II. Relation of organ damage to severity of sepsis evaluated by a newly developed morphological scoring system.
Schlag G; Redl H; van Vuuren CJ; Davies J
Circ Shock; 1992 Dec; 38(4):253-63. PubMed ID: 1292889
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an endotoxemic baboon model of metabolic and organ dysfunction.
Lindsey DC; Emerson TE; Thompson TE; John AE; Duerr ML; Valdez CM; Kuo HS; Bouffard RB; Irwin RG; Canivel D
Circ Shock; 1991 Jul; 34(3):298-310. PubMed ID: 1653118
[TBL] [Abstract][Full Text] [Related]
15. Complement and leukocyte activation in septic baboons.
Bengtsson A; Redl H; Paul E; Schlag G; Mollnes TE; Davies J
Circ Shock; 1993 Feb; 39(2):83-8. PubMed ID: 8490996
[TBL] [Abstract][Full Text] [Related]
16. Study of septic shock in the non-human primate: relationship of pathophysiological response to therapy with anti-TNF antibody.
Hinshaw LB; Emerson TE; Chang AC; Duerr M; Peer G; Fournel M
Circ Shock; 1994 Dec; 44(4):221-9. PubMed ID: 7628065
[TBL] [Abstract][Full Text] [Related]
17. Big-endothelin release in baboon bacteremia is partially TNF dependent.
Redl H; Schlag G; Bahrami S; Kargl R; Hartter W; Woloszczuk W; Davies J
J Lab Clin Med; 1994 Dec; 124(6):796-801. PubMed ID: 7798792
[TBL] [Abstract][Full Text] [Related]
18. Markers of endotoxin related leukocyte activation and injury mechanisms.
Redl H; Schlag G; Bahrami S; Dinges HP; Schade U; Ceska M
Prog Clin Biol Res; 1991; 367():83-100. PubMed ID: 1924434
[No Abstract] [Full Text] [Related]
19. Protective effects of reconstituted high-density lipoprotein in rabbit gram-negative bacteremia models.
Hubsch AP; Casas AT; Doran JE
J Lab Clin Med; 1995 Dec; 126(6):548-58. PubMed ID: 7490514
[TBL] [Abstract][Full Text] [Related]
20. Anti-TNF treatment of baboons with sepsis reduces TNF-alpha, IL-6 and IL-8, but not the degree of complement activation.
Bengtsson A; Redl H; Schlag G; Högåsen K; Götze O; Mollnes TE
Scand J Immunol; 1998 Nov; 48(5):509-14. PubMed ID: 9822260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
